Cochrane Database of Systematic Reviews
Cochrane Library
Cochrane Database of Systematic Reviews
Mechanical methods for induction of labour (Review)
de Vaan MDT, ten Eikelder MLG, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KWM, Mol BWJ, Boulvain M
de Vaan MDT, ten Eikelder MLG, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KWM, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD001233. DOI: 10.1002/14651858.CD001233.pub3.
www.cochranelibrary.com
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.
https://doi.org/10.1002%2F14651858.CD001233.pub3
https://www.cochranelibrary.com
Cochrane Library
Trusted evidence. Informed decisions. Better health.
Cochrane Database of Systematic Reviews
T A B L E O F C O N T E N T S HEADER………………………………………………………………………………………………………………………………………………………………………………… 1 ABSTRACT…………………………………………………………………………………………………………………………………………………………………………….. 1 PLAIN LANGUAGE SUMMARY………………………………………………………………………………………………………………………………………………….. 2 SUMMARY OF FINDINGS………………………………………………………………………………………………………………………………………………………… 4 BACKGROUND………………………………………………………………………………………………………………………………………………………………………. 9 OBJECTIVES………………………………………………………………………………………………………………………………………………………………………….. 9 METHODS…………………………………………………………………………………………………………………………………………………………………………….. 9 RESULTS……………………………………………………………………………………………………………………………………………………………………………….. 13
Figure 1………………………………………………………………………………………………………………………………………………………………………….. 14 Figure 2………………………………………………………………………………………………………………………………………………………………………….. 19 Figure 3………………………………………………………………………………………………………………………………………………………………………….. 20 Figure 4………………………………………………………………………………………………………………………………………………………………………….. 24 Figure 5………………………………………………………………………………………………………………………………………………………………………….. 25 Figure 6………………………………………………………………………………………………………………………………………………………………………….. 26 Figure 7………………………………………………………………………………………………………………………………………………………………………….. 27 Figure 8………………………………………………………………………………………………………………………………………………………………………….. 28 Figure 9………………………………………………………………………………………………………………………………………………………………………….. 29 Figure 10………………………………………………………………………………………………………………………………………………………………………… 30 Figure 11………………………………………………………………………………………………………………………………………………………………………… 31 Figure 12………………………………………………………………………………………………………………………………………………………………………… 32
DISCUSSION………………………………………………………………………………………………………………………………………………………………………….. 61 AUTHORS’ CONCLUSIONS……………………………………………………………………………………………………………………………………………………… 64 ACKNOWLEDGEMENTS………………………………………………………………………………………………………………………………………………………….. 65 REFERENCES………………………………………………………………………………………………………………………………………………………………………… 66 CHARACTERISTICS OF STUDIES……………………………………………………………………………………………………………………………………………… 89 DATA AND ANALYSES……………………………………………………………………………………………………………………………………………………………… 221
Analysis 1.1. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 1 Vaginal delivery not achieved in 24 hours………………………………………………………………………………………………………………………………………………….
222
Analysis 1.2. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 2 Uterine hyperstimulation with FHR changes………………………………………………………………………………………………………………………………….
223
Analysis 1.3. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 3 Caesarean section…. 223 Analysis 1.4. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 4 Serious neonatal morbidity/perinatal death………………………………………………………………………………………………………………………………………………..
224
Analysis 1.5. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 5 Serious maternal morbidity or death…………………………………………………………………………………………………………………………………………………………..
225
Analysis 1.6. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 6 Oxytocin augmentation………………………………………………………………………………………………………………………………………………………………….
225
Analysis 1.7. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 7 Uterine hyperstimulation without fetal heart rate changes…………………………………………………………………………………………………………….
226
Analysis 1.8. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 8 Uterine rupture…… 226 Analysis 1.9. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 9 Epidural analgesia…. 226 Analysis 1.10. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 10 Instrumental vaginal delivery……………………………………………………………………………………………………………………………………………………………….
227
Analysis 1.11. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 11 Meconium- stained liquor…………………………………………………………………………………………………………………………………………………………………..
227
Analysis 1.12. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 12 Apgar score < 7 at 5 minutes…………………………………………………………………………………………………………………………………………………………………
228
Analysis 1.13. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 13 Neonatal intensive care unit admission…………………………………………………………………………………………………………………………………………..
228
Analysis 1.14. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 14 Perinatal death…. 229 Analysis 1.15. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 15 Postpartum haemorrhage…………………………………………………………………………………………………………………………………………………………………..
229
Mechanical methods for induction of labour (Review) Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.
i
Cochrane Library
Trusted evidence. Informed decisions. Better health.
Cochrane Database of Systematic Reviews
Analysis 1.16. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 16 Women not satisfied…………………………………………………………………………………………………………………………………………………………………………..
230
Analysis 1.17. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 17 Maternal fever during labour…………………………………………………………………………………………………………………………………………………………………..
230
Analysis 1.18. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 18 Antibiotics during labour……………………………………………………………………………………………………………………………………………………………………………..
230
Analysis 1.19. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 19 Chorioamnionitis……………………………………………………………………………………………………………………………………………………………..
231
Analysis 1.20. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 20 Endometritis…… 231 Analysis 1.21. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 21 Fetal distress…… 231 Analysis 1.22. Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women, Outcome 22 Umbilical artery pH < 7.10…………………………………………………………………………………………………………………………………………………………………………
232
Analysis 2.1. Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours………………………………………………………………………………………………………………………………………………….
233
Analysis 2.2. Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes………………………………………………………………………………………………………………………………….
233
Analysis 2.3. Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all primiparae, Outcome 3 Caesarean section…………………………………………………………………………………………………………………………………………………………………………….
233
Analysis 2.4. Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all primiparae, Outcome 4 Serious neonatal morbidity/perinatal death………………………………………………………………………………………………………………………………………………..
234
Analysis 2.5. Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all primiparae, Outcome 5 Serious maternal morbidity or death…………………………………………………………………………………………………………………………………………………………..
234
Analysis 3.1. Comparison 3 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all multiparae, Outcome 1 Vaginal delivery not achieved in 24 hours………………………………………………………………………………………………………………………………………………….
234
Analysis 3.2. Comparison 3 Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all multiparae, Outcome 2 Caesarean section…………………………………………………………………………………………………………………………………………………………………………….
235
Analysis 4.1. Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women, Outcome 1 Vaginal delivery not achieved in 24 hours…………………………………………………………………………………………………………………………………….
236
Analysis 4.2. Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women, Outcome 2 Uterine hyperstimulation with FHR changes………………………………………………………………………………………………………………………………….
237
Analysis 4.3. Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women, Outcome 3 Caesarean section…………………………………………………………………………………………………………………………………………………………………………….
237
Analysis 4.4. Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women, Outcome 4 Serious neonatal morbidity/perinatal death………………………………………………………………………………………………………………………………….
237
Analysis 4.5. Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women, Outcome 5 Cervix unfavourable/unchanged aHer 24 hours……………………………………………………………………………………………………………………………
238
Analysis 4.6. Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women, Outcome 6 Oxytocin augmentation………………………………………………………………………………………………………………………………………………………………….
238
Analysis 4.7. Comparison 4…
